AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
LIRAGLUTIDE
9 registrations across 5 African markets— 8 active
Markets with LIRAGLUTIDE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| VICTOZA SOLUTION; INJECTION | 🇿🇼Zimbabwe | NOVO-NORDISK A/S | active | Jun 2031 |
| LIRAGLUTIDE 6 mg/ml CIPLA | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | active | Jan 2030 |
| GILIPTRA | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | active | Jan 2030 |
| Saxenda 6 mg/mL Solution for Injection in Pre-filled Pen** Solution for injection | 🇳🇬Nigeria | Novo Nordisk Pharma Ltd | active | Oct 2025 |
| Victoza® 6 mg/mL Solution for Injection in Prefilled Pen Injection | 🇳🇬Nigeria | Nonyez Vent. Ltd | active | Sept 2025 |
| VICTOZA Solution injectable / 6 mg/ml | 🇹🇳Tunisia | NOVO NORDISK A/S Bagsvaerd | expired | Sept 2013 |
| SAXENDA | 🇿🇦South Africa | Novo Nordisk (Pty) Ltd û (Rivonia) | active | Jan 1900 |
| VICTOZA | 🇿🇦South Africa | Novo Nordisk (Pty) Ltd û (Rivonia) | active | Jan 1900 |
| VICTOZA 6MG/ML SC SOLUTION INJECTABLE EN STYLO PRE-REMPLI FLACON DE 3ML | 🇨🇮Côte d'Ivoire | NOVO NORDISK A/S | active | — |
LIRAGLUTIDE in Africa — Regulatory Overview
LIRAGLUTIDE is registered across 5 African markets with 9 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Nigeria, Côte d'Ivoire, Tunisia and 1 more. AfricaRegulatory refreshes this data daily from official government sources.
Of the 9 registrations, 8 (89%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.